Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$42.43 - $70.83 $7.52 Million - $12.6 Million
177,200 New
177,200 $12.1 Million
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $1.73 Million - $2.27 Million
30,800 Added 102.67%
60,800 $4.2 Million
Q4 2023

Feb 14, 2024

SELL
$59.06 - $75.72 $6.53 Million - $8.37 Million
-110,500 Reduced 78.65%
30,000 $2.22 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $9.26 Million - $13.9 Million
140,500 New
140,500 $9.58 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.